Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 May 12;2(2):ofv070. doi: 10.1093/ofid/ofv070

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 1. — (A) Time to incident anogenital warts. Kaplan–Meier estimates for anogenital wart incidence are presented by human immunodeficiency virus (HIV)-1 status (solid line for HIV-1-infected, dashed line for HIV-1-uninfected). Anogenital wart incidence in HIV-1-infected men was 7.6 per 100 person-years (PY) versus 4.9 per 100 PY in uninfected men (log-rank P = .009). (B) Time to anogenital wart clearance. Kaplan–Meier estimates for anogenital wart clearance are presented by HIV-1 status (solid line for HIV-1-infected, dashed line for HIV-1-uninfected). Anogenital wart clearance in HIV-1-infected men was 96.7 per 100 PY versus 253.4 per 100 PY in HIV-1-uninfected men (unadjusted hazards ratio, 0.42; 95% confidence interval, .27–.64; P < .001).